Drawing for FIBROMAP

USPTO serial 99575365

FIBROMAP

Status 641Office Action
Filing date
Jan 2, 2026
Status date
May 1, 2026
Registration date
Examiner
GILBERT, REBECCA L

Need help with FIBROMAP?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Deadline: 1 Aug 2026

Office Action issues

The USPTO has refused the mark because it describes your services, rejected the Class 9 specimen as mere advertising, and requires a physical domicile address along with clarifications for the service descriptions.

Owner

  • PHARMANEST INC

    Princeton, NJ, US

Goods and services

ClassDescriptionStatusFirst use
009Downloadable cloud-based software for detecting and analyzing fibrosis and other fibrillar protein histological phenotypes for scientific use; Downloadable cloud-based software for scientific research, namely, for collecting, processing, and visualizing histological features and phenotypes of fibrosis and other fibrillar proteins in connection with scientific or medical research; Downloadable cloud-based software for analyzing spatially resolved tissue-based datasets; Downloadable cloud-based software for analyzing spatially resolved datasets, in particular analyzing spatially resolved single-fiber datasets and spatially resolved single-cell datasets, individually or in conjunction; Downloadable cloud-based software for visualizing spatially resolved single-fiber datasets and spatially resolved single-cell datasets and their phenotypic clusters, individually or in conjunction; Downloadable cloud-based software for analyzing, measuring and quantifying phenotypes of fibrosis or other fibrillar proteins in images using advanced computational and clustering techniquesACTIVEMay 1, 2025
042Cloud computing featuring software for use in the fields of artificial intelligence; Cloud computing featuring software for use in the fields of biosciences, in particular pathology, histology, histopathology, spatial biology, cytopathology, biology, botany, pharmacology, medical, veterinary; Cloud computing featuring software for use in archiving, viewing and annotating digitized images of microscope slides; Cloud computing featuring software for use in providing digital pathology services, in particular web-based digital pathology services; Cloud computing featuring software for use in analyzing, measuring and quantifying the phenotypic traits of fibrosis or other fibrillar proteins in images using advanced computational and clustering techniques; Cloud computing featuring software for use in analyzing spatially resolved datasets, in particular analyzing spatially resolved single-fiber datasets and spatially resolved single-cell datasets, individually or in conjunction; Cloud computing featuring software for use in visualizing spatially resolved single-fiber datasets and spatially resolved single-cell datasets and their phenotypic clusters, individually or in conjunction; Cloud computing featuring software for use in associating information with digitized images of microscope slides, in particular pathological data, clinical data, clinical history data, research data, reference data, analysis data, statistical data; Cloud computing featuring software for use in quantifying phenotypes of fibrosis; Cloud computing featuring software for use in discovering novel biomarkers of fibrosisACTIVEMay 1, 2025

Prosecution history

DateCodeEvent
Jul 1, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 1, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 1, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
May 1, 2026GNRTNON-FINAL ACTION E-MAILED
May 1, 2026CNRTNON-FINAL ACTION WRITTEN
May 1, 2026DOCKASSIGNED TO EXAMINER
Apr 21, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 2, 2026MAFRAPPLICATION FILING RECEIPT MAILED
Jan 2, 2026NWAPNEW APPLICATION ENTERED

Related guidance